Literature DB >> 16261539

Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real-time PCR quantification of mycobacterial DNA.

Simona Rondini1, Catherine Horsfield, Ernestina Mensah-Quainoo, Thomas Junghanss, Sebastian Lucas, Gerd Pluschke.   

Abstract

The distribution of M. ulcerans in Buruli ulcer lesions was analysed by IS2404 real-time PCR quantification of M. ulcerans DNA and by semi-quantitative microscopic assessment of the number of acid-fast bacilli (AFB). Mycobacterial burden was compared with histopathological changes. Focal distribution of tissue destruction extending into areas with high and low mycobacterial burden was a feature in all lesions analysed. Even where most of the mycobacteria were washed out of ulcerative lesions, peaks of mycobacterial DNA and AFB in the necrotic base of the ulcers still marked the position of the primary infection focus. Significant amounts of mycobacterial DNA and microcolonies were also present in samples from more peripheral regions and occasionally in excised margins of macroscopically and histologically healthy-appearing excised tissue margins. Additional peaks of mycobacterial DNA clearly marked sites where satellite lesions were developing. Even when granulomas provided evidence for the development of cell-mediated immunity, development of satellite lesions by contiguous spreading was not completely prevented. Areas free of mycobacterial DNA were found between primary and secondary infection foci and around scarring tissue of healing lesions. These results demonstrate that IS2404 real-time PCR analysis is a better tool than the less sensitive and only semi-quantitative microscopic enumeration of AFB for studying the dynamics of M. ulcerans infection in situ. Copyright 2005 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16261539     DOI: 10.1002/path.1864

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  22 in total

1.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

2.  What does detection of Mycobacterium ulcerans DNA in the margin of an excised Buruli ulcer lesion tell us?

Authors:  Simona Rondini; Ernestina Mensah-Quainoo; Thomas Junghanss; Gerd Pluschke
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

3.  In Vivo Imaging of Bioluminescent Mycobacterium ulcerans: A Tool to Refine the Murine Buruli Ulcer Tail Model.

Authors:  Till F Omansen; Renee A Marcsisin; Brendon Y Chua; Weiguang Zeng; David C Jackson; Jessica L Porter; Ymkje Stienstra; Tjip S van der Werf; Timothy P Stinear
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

4.  Excision of pre-ulcerative forms of Buruli ulcer disease: a curative treatment?

Authors:  K-H Herbinger; D Brieske; J Nitschke; V Siegmund; W Thompson; E Klutse; N Y Awua-Boateng; E Bruhl; L Kunaa; M Schunk; O Adjei; T Löscher; G Bretzel
Journal:  Infection       Date:  2008-12-03       Impact factor: 3.553

Review 5.  Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.

Authors:  Jeannette Guarner
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

6.  Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?

Authors:  Marie-Thérèse Ruf; Ghislain Emmanuel Sopoh; Luc Valère Brun; Ange Dodji Dossou; Yves Thierry Barogui; Roch Christian Johnson; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

7.  Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Authors:  Marie-Thérèse Ruf; Annick Chauty; Ambroise Adeye; Marie-Françoise Ardant; Hugues Koussemou; Roch Christian Johnson; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

8.  Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.

Authors:  Alexandra G Fraga; Teresa G Martins; Egídio Torrado; Kris Huygen; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

9.  Enumeration of Mycobacterium leprae using real-time PCR.

Authors:  Richard W Truman; P Kyle Andrews; Naoko Y Robbins; Linda B Adams; James L Krahenbuhl; Thomas P Gillis
Journal:  PLoS Negl Trop Dis       Date:  2008-11-04

10.  Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.

Authors:  Daniela Schütte; Alphonse Um-Boock; Ernestina Mensah-Quainoo; Peter Itin; Peter Schmid; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.